
The health tech and medtech investment landscape in the age of Covid-19
Fredrikson & Byron attorneys Ryan Johnson and Jeffrey Steinle share insights on how Covid-19 is continuing to transform the health tech and medtech landscape.
Fredrikson & Byron attorneys Ryan Johnson and Jeffrey Steinle share insights on how Covid-19 is continuing to transform the health tech and medtech landscape.
In a Spotlight Video interview, Fredrikson & Byron Shareholders and Co-chairs of the firm's life sciences group, Jeff Steinle and Ryan Johnson, talked about the deal-making environment in healthcare and how the Covid-19 pandemic has impacted it.
For artificial intelligence to gain wider interest from clinicians, the way the algorithms arrive at their conclusions needs to be understandable.
Q&A with Fredrikson & Byron attorneys Ryan Johnson and Jeff Steinle